logo

For the Inventor, By the Inventor

Zionsville, IN, United States of America

Wei He

This inventor holds 16 USPTO granted patents and 15 published patent applications and 4 EPO patents. Top assignees: Accutar Biotechnology Inc., Tiger Biotherapeutics Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei He. Retrieved from https://idiyas.com/inventor/wei-he-1ei8hx4j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 87.5

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal13 out of 20 
 
Accutar Biotechnology Inc.
 patents
silverMedal3 out of 3 
 
Tiger Biotherapeutics Inc.
 patents

Years Active: 2020-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12338248 - Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors (2025-06-24),
2. 12331061 - Compounds having BET, estrogen receptor, and androgen receptor degradation activity and uses thereof (2025-06-17),
3. 12195459 - Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof (2025-01-14),
4. 12168058 - Glutarimide-containing KRAS-mutant degrader compounds and uses thereof (2024-12-17),
5. 12110291 - Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereof (2024-10-08),
6. 11642342 - Combinations of estrogen receptor degraders and cyclin-dependent kinase inhibitors for treating cancer (2023-05-09),
7. 11535606 - Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof (2022-12-27),
8. 11530222 - Substituted pyrrolopyrimidine and pyrazolopyrimidine as Bruton's tyrosine kinase (BTK) degraders (2022-12-20),
9. 11420956 - Ureas having Androgen Receptor degradation activity and uses thereof (2022-08-23),
10. 11312702 - Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof (2022-04-26),
11. 11261178 - Chroman derivatives having estrogen receptor degradation activity and uses thereof (2022-03-01),
12. 11220490 - Ureas having androgen receptor degradation activity and uses thereof (2022-01-11),
13. 11117885 - Compounds having estrogen receptor alpha degradation activity and uses thereof (2021-09-14),
14. 10836749 - Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof (2020-11-17),
15. 10800770 - Chroman derivatives having estrogen receptor degradation activity and uses thereof (2020-10-13),

Title: Inventor Wei He: Pioneering Innovations in Zionsville

Introduction: Wei He is a distinguished inventor based in Zionsville, Indiana, known for his groundbreaking contributions to the field of technology and engineering.

Latest Patents: Wei He holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to driving progress through innovation.

Career Highlights: With a career spanning over two decades, Wei He has worked with leading research institutions and technology companies, playing a key role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Wei He has collaborated with top engineers, scientists, and inventors, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Wei He's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and engineers, making him a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…